Maximus Inc. (MMS) shares plunged 5.21% in Thursday's trading session after the company reported mixed results for the fiscal first quarter ended December 31, 2024.
While the government health services provider posted adjusted earnings per share of $1.61, exceeding analyst estimates of $1.37, it missed on fourth-quarter EPS expectations, reporting $0.69 versus the consensus estimate of $1.06.
On the positive side, Maximus' revenue for the quarter came in at $1.4 billion, surpassing the $1.29 billion forecasted by analysts. Additionally, the company raised its fiscal 2025 adjusted EPS guidance to a range of $5.90 to $6.20, up from its previous outlook of $5.70 to $6.00.
免责声明：投资有风险，本文并非投资建议，以上内容不应被视为任何金融产品的购买或出售要约、建议或邀请，作者或其他用户的任何相关讨论、评论或帖子也不应被视为此类内容。本文仅供一般参考，不考虑您的个人投资目标、财务状况或需求。TTM对信息的准确性和完整性不承担任何责任或保证，投资者应自行研究并在投资前寻求专业建议。